Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Galbraith

Showing results (111-120 of 144) with videos related to

Pageof 15
Sort By:
Cell Reports|March 10, 2023
FAM193A is a positive regulator of p53 activityMaria M Szwarc, Anna L Guarnieri, Molishree Joshi, et al.
Elife|July 30, 2016
Trisomy 21 consistently activates the interferon responseKelly D Sullivan, Hannah C Lewis, Amanda A Hill, et al.
Cell Reports|January 15, 2026
Altered hepatic metabolism in Down syndromeLauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Altered Hepatic Metabolism in Down SyndromeLauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Annals of Clinical and Translational Neurology|February 25, 2025
Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression DisorderJonathan D Santoro, Neetha Paul Eduthan, Mellad M Khoshnood, et al.
Elife|February 10, 2025
Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndromeKira A Cozzolino, Lynn Sanford, Samuel Hunter, et al.
Cell Death and Differentiation|January 21, 2023
Cell differentiation modifies the p53 transcriptional program through a combination of gene silencing and constitutive transactivationRoubina Tatavosian, Micah G Donovan, Matthew D Galbraith, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndromeKira Cozzolino, Lynn Sanford, Samuel Hunter, et al.
Nature Communications|June 28, 2024
Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndromeMicah G Donovan, Neetha P Eduthan, Keith P Smith, et al.
Cell Reports|December 28, 2022
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndromePaula Araya, Kohl T Kinning, Christina Coughlan, et al.
Pageof 15

Showing results (111-120 of 144) with videos related to

Sort By:
Pageof 15
Cell Reports|March 10, 2023
FAM193A is a positive regulator of p53 activityMaria M Szwarc, Anna L Guarnieri, Molishree Joshi, et al.
Elife|July 30, 2016
Trisomy 21 consistently activates the interferon responseKelly D Sullivan, Hannah C Lewis, Amanda A Hill, et al.
Cell Reports|January 15, 2026
Altered hepatic metabolism in Down syndromeLauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
Altered Hepatic Metabolism in Down SyndromeLauren N Dunn, Brian F Niemeyer, Neetha P Eduthan, et al.
Annals of Clinical and Translational Neurology|February 25, 2025
Evidence of blood-brain barrier dysfunction and CSF immunoglobulin synthesis in Down Syndrome Regression DisorderJonathan D Santoro, Neetha Paul Eduthan, Mellad M Khoshnood, et al.
Elife|February 10, 2025
Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndromeKira A Cozzolino, Lynn Sanford, Samuel Hunter, et al.
Cell Death and Differentiation|January 21, 2023
Cell differentiation modifies the p53 transcriptional program through a combination of gene silencing and constitutive transactivationRoubina Tatavosian, Micah G Donovan, Matthew D Galbraith, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Mediator kinase inhibition suppresses hyperactive interferon signaling in Down syndromeKira Cozzolino, Lynn Sanford, Samuel Hunter, et al.
Nature Communications|June 28, 2024
Variegated overexpression of chromosome 21 genes reveals molecular and immune subtypes of Down syndromeMicah G Donovan, Neetha P Eduthan, Keith P Smith, et al.
Cell Reports|December 28, 2022
IGF1 deficiency integrates stunted growth and neurodegeneration in Down syndromePaula Araya, Kohl T Kinning, Christina Coughlan, et al.
Pageof 15